Health News Roundup: CDC investigates lung illnesses linked to e-cigarette use; Novartis executive sold shares before drug data manipulation made public

Following is a summary of current health news briefs.

Novartis executive sold shares before drug data manipulation made public

An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration (FDA) announced data from tests of its gene therapy Zolgensma had been manipulated. Novartis announced the stock sale by an executive member of the board of directors or a member of the executive committee in a Swiss stock exchange filing dated July 19. The sale was first reported by Swiss newspaper SonntagsZeitung on Sunday.

CDC investigates lung illnesses linked to e-cigarette use

The Centers for Disease Control and Prevention is investigating a "cluster" of lung illnesses linked to e-cigarette use after such cases were reported in 14 states. The CDC is working with health departments in Wisconsin, Illinois, California, Indiana and Minnesota on the investigation. Since June 28, states have reported 94 possible cases of severe lung illness tied to vaping, with 30 occurring in Wisconsin, according to a CDC statement on Saturday.

E.coli in water forces Tokyo to cancel swimming at Paratriathlon World Cup

High levels of E.coli bacteria forced Tokyo officials to cancel the swimming segment of Saturday's Paratriathlon World Cup, raising concerns about next year's Summer Olympic and Paralympic Games. Water quality tests at Odaiba Marine Park found fecal bacteria levels far exceeded accepted limits, organizers said, forcing them to pull the plug on the swimming events.

Also Read: Detained Baring Vostok executive Delpal to be placed under house arrest -Ifax

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)